The Board of Directors of XVIVO Perfusion AB (publ) (“XVIVO”) has today appointed Lena Hagman as deputy CEO. She will remain in her role as COO.
Lena Hagman has been a member of XVIVO’s management team since December 2022 and has a long career in the medical technology industry, with more than 20 years of global experience in leading positions with responsibility in R&D, supply chain and quality regulatory/medical affairs. Prior to joining XVIVO, Lena Hagman has held several leading roles in Swedish and global medical technology companies.
November 14, 2024
Mölndal, Sweden
The Board of Directors
XVIVO Perfusion AB (publ)